An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies
Conditions: Advanced Solid Tumor; Lymphoma Intervention: Drug: ALPN-202 Sponsor: Alpine Immune Sciences, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials